Written by Kaunain Sheriff M, Amitabh Sinha | New Delhi, Pune | Updated: December 9, 2020 10:02:09 am Vials of Covishield, the Indian version of the AstraZeneca-Oxford vaccine, at the Serum Institute of India in Pune, India. (Reuters photo) Three vaccine developers have submitted applications to the Central Drug Standards …
Read More »
As India approaches a breakthrough in the battle against the COVID-19 pandemic, the Union Health Ministry has reported that some of the vaccine candidates ‘may be licensed’ in the coming weeks. The development comes as three pharmaceutical companies have already applied for Emergency Use Authorization (USA) for their COVID-19 vaccines. …
Read More »
Hopes for an early vaccine for coronavirus disease (Covid-19) in India have been rekindled after three companies, within days of each other, applied for emergency use authorization (USA) of their respective candidate vaccines in the country. While Pfizer Inc of the United States was the first to apply on December …
Read More »
Written by Prabha Raghavan, Anuradha Mascarenhas | New Delhi, Pune | Updated: December 8, 2020 7:15:08 am Hyderabad-based Bharat Biotech has included interim data from early and mid-stage human trials of its Covaxin vaccine candidate. (Archive) In its application for emergency use approval, Hyderabad-based Bharat Biotech has included interim data …
Read More »
NEW DELHI: Hyderabad-based Bharat Biotech submitted an application for an emergency use authorization for Covaxin on Monday, becoming the third company to seek such regulatory approval in India after Pfizer and Serum Institute of India (SII) . Covaxin is the first fully locally developed candidate vaccine against Covid-19 to be …
Read More »
Written by Payal Banerjee | New Delhi | Updated: December 7, 2020 10:19:17 am The Serum Institute of India on Sunday requested the Comptroller General of Drugs of India (DCGI) for emergency use authorization for its Oxford Covid-19 vaccine in the country. (PTI file photo) The Serum Institute of India …
Read More »
A senior Health Ministry official told The Hindu that Covishield is logistically more feasible for use and distribution in India, as it stores well between two and eight degrees Celsius. The Serum Institute of India (SII) said on Monday that it had applied to the Controller General of Drugs of …
Read More »
After US pharmaceutical giant Pfizer, Serum Institute of India (SII) applied on Sunday to the Comptroller General of Medicines of India (DCGI) for an emergency use authorization for the COVID-19 Covidshield vaccine from Oxford in the country. On Twitter, SII CEO Adar Poonawalla reported that the company has applied for …
Read More »
Serum Institute of India, Pune became the second company after Pfizer to apply for an emergency use authorization for its trial vaccine, the Oxford COVID-19 vaccine (called COVISHIELD) in the country. The vaccine is currently undergoing phase III testing in India and other parts of the world. The news, which …
Read More »
NEW DELHI: The government expects two Covid-19 vaccines, Covishield from Oxford-AstraZeneca and Covaxin from Bharat Biotech, to be available in January and about four vaccines by the end of April, increasing prospects for adequate supplies to inoculate a priority of Rs 30 crore. population in July, an official said. While …
Read More »